1. Aabakken L, Dybdahl JH, Larsen S, Mowinckel P, Osnes M, Quiding H (1989a) A double-blind comparison of gastrointestinal effects of ibuprofen standard and ibuprofen sustained release assessed by means of endoscopy and 51Cr-labelled erythrocytes. Scand J Gastroenterol 24:307–313
2. Aabakken L, Dybdahl JH, Eidsaunet W, Haaland A, Larsen S, Osnes M (1989b) Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers. Scand J Gastroenterol 24:1007–1013
3. Arroyo M, Lanas A (2006) NSAID-induced gastrointestinal damage. Minerva Gastroenterol Dietol 52:249–259
4. Ashraf E, Ford L, Geetha R, Cooper S (1999) Safety profile of ibuprofen suspension in young children. Inflammopharmacology 7:219–225
5. Ashraf E, Cooper S, Kellstein D, Jayawardena S (2001) Safety profile of non-prescription ibuprofen in the elderly osteoarthritic patient: a meta-analysis. Inflammopharmacology 9:35–41